Aspirin and extended-release dipyridamole capsules had a market value of roughly $158 million for the 12 months ended April 2019, according to IQVIA, although actual generic market values are expected to be lower.
The Association for Accessible Medicines' letter to U.S. Trade Representative Robert Lighthizer supports excluding pharmaceuticals and certain pharmaceutical inputs from the expanded list of Chinese exports that will face tariffs.